(MSTR) MicroStrategy - Ratings and Ratios
Bitcoin Exposure, Analytics Software, Enterprise Intelligence
EPS (Earnings per Share)
Revenue
Dividends
Currently no dividends paid| Risk via 5d forecast | |
|---|---|
| Volatility | 61.5% |
| Value at Risk 5%th | 92.7% |
| Relative Tail Risk | -8.34% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -0.50 |
| Alpha | -79.95 |
| CAGR/Max DD | 1.70 |
| Character TTM | |
|---|---|
| Hurst Exponent | 0.489 |
| Beta | 2.076 |
| Beta Downside | 1.255 |
| Drawdowns 3y | |
|---|---|
| Max DD | 67.93% |
| Mean DD | 21.00% |
| Median DD | 19.62% |
Description: MSTR MicroStrategy December 02, 2025
Strategy Inc. (formerly MicroStrategy) operates as a “bitcoin treasury company,” using its balance sheet to acquire and hold large quantities of Bitcoin while also issuing equity and fixed-income securities that give investors indirect exposure to the cryptocurrency’s price movements. In parallel, the firm sells AI-enabled enterprise analytics platforms-Strategy One for low-code insight delivery and Strategy Mosaic for unified data governance across heterogeneous sources.
Key data points (as of Q3 2024): the company’s Bitcoin holdings total roughly 150,000 BTC, representing over 30 % of its total assets; revenue from the analytics segment grew ~18 % YoY, driven by rising demand for generative-AI tools in the enterprise software market; and the firm’s free cash flow remains modest (~$50 M) because most cash is tied up in Bitcoin purchases, making the stock’s performance highly sensitive to Bitcoin price volatility. Sector-level drivers include accelerating AI adoption across industries and the broader trend of corporates using digital assets as a treasury hedge.
For a deeper quantitative assessment, consult ValueRay’s MSTR dashboard to explore the latest risk-adjusted metrics and scenario analyses.
Piotroski VR‑10 (Strict, 0-10) 4.0
| Net Income (7.92b TTM) > 0 and > 6% of Revenue (6% = 28.5m TTM) |
| FCFTA -0.51 (>2.0%) and ΔFCFTA 12.03pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue -23.19% (prev -21.84%; Δ -1.35pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA -0.00 (>3.0%) and CFO -62.9m <= Net Income 7.92b (YES >=105%, WARN >=100%) |
| Net Debt (8.17b) to EBITDA (11.00b) ratio: 0.74 <= 3.0 (WARN <= 3.5) |
| Current Ratio 0.66 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (304.0m) change vs 12m ago 54.09% (target <= -2.0% for YES) |
| Gross Margin 70.12% (prev 73.56%; Δ -3.44pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 1.16% (prev 5.60%; Δ -4.44pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio 156.0 (EBITDA TTM 11.00b / Interest Expense TTM 70.4m) >= 6 (WARN >= 3) |
Altman Z'' 3.91
| (A) -0.00 = (Total Current Assets 214.0m - Total Current Liabilities 324.1m) / Total Assets 73.62b |
| (B) 0.26 = Retained Earnings (Balance) 18.95b / Total Assets 73.62b |
| (C) 0.27 = EBIT TTM 10.98b / Avg Total Assets 40.98b |
| (D) 1.22 = Book Value of Equity 18.94b / Total Liabilities 15.50b |
| Total Rating: 3.91 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 54.91
| 1. Piotroski 4.0pt |
| 2. FCF Yield -69.84% |
| 3. FCF Margin data missing |
| 4. Debt/Equity 0.14 |
| 5. Debt/Ebitda 0.74 |
| 6. ROIC - WACC (= 5.76)% |
| 7. RoE 19.76% |
| 8. Rev. Trend -49.47% |
| 9. EPS Trend 24.05% |
What is the price of MSTR shares?
Over the past week, the price has changed by -1.04%, over one month by -13.33%, over three months by -55.39% and over the past year by -47.62%.
Is MSTR a buy, sell or hold?
- Strong Buy: 7
- Buy: 5
- Hold: 0
- Sell: 0
- Strong Sell: 1
What are the forecasts/targets for the MSTR price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 489.6 | 211.5% |
| Analysts Target Price | 489.6 | 211.5% |
| ValueRay Target Price | 172 | 9.4% |
MSTR Fundamental Data Overview December 27, 2025
P/E Trailing = 6.5152
P/E Forward = 2.6674
P/S = 96.0242
P/B = 0.8715
P/EG = 3.09
Beta = 3.41
Revenue TTM = 474.9m USD
EBIT TTM = 10.98b USD
EBITDA TTM = 11.00b USD
Long Term Debt = 8.17b USD (from longTermDebt, last quarter)
Short Term Debt = 316.0k USD (from shortTermDebt, last quarter)
Debt = 8.22b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 8.17b USD (from netDebt column, last quarter)
Enterprise Value = 53.77b USD (45.61b + Debt 8.22b - CCE 54.3m)
Interest Coverage Ratio = 156.0 (Ebit TTM 10.98b / Interest Expense TTM 70.4m)
FCF Yield = -69.84% (FCF TTM -37.56b / Enterprise Value 53.77b)
FCF Margin = -7907 % (FCF TTM -37.56b / Revenue TTM 474.9m)
Net Margin = 1667 % (Net Income TTM 7.92b / Revenue TTM 474.9m)
Gross Margin = 70.12% ((Revenue TTM 474.9m - Cost of Revenue TTM 141.9m) / Revenue TTM)
Gross Margin QoQ = 70.46% (prev 68.77%)
Tobins Q-Ratio = 0.73 (Enterprise Value 53.77b / Total Assets 73.62b)
Interest Expense / Debt = 0.23% (Interest Expense 18.9m / Debt 8.22b)
Taxrate = 28.06% (1.09b / 3.87b)
NOPAT = 7.90b (EBIT 10.98b * (1 - 28.06%))
Current Ratio = 0.66 (Total Current Assets 214.0m / Total Current Liabilities 324.1m)
Debt / Equity = 0.14 (Debt 8.22b / totalStockholderEquity, last quarter 58.12b)
Debt / EBITDA = 0.74 (Net Debt 8.17b / EBITDA 11.00b)
Debt / FCF = -0.22 (negative FCF - burning cash) (Net Debt 8.17b / FCF TTM -37.56b)
Total Stockholder Equity = 40.06b (last 4 quarters mean from totalStockholderEquity)
RoA = 10.75% (Net Income 7.92b / Total Assets 73.62b)
RoE = 19.76% (Net Income TTM 7.92b / Total Stockholder Equity 40.06b)
RoCE = 22.76% (EBIT 10.98b / Capital Employed (Equity 40.06b + L.T.Debt 8.17b))
RoIC = 17.36% (NOPAT 7.90b / Invested Capital 45.48b)
WACC = 11.61% (E(45.61b)/V(53.83b) * Re(13.67%) + D(8.22b)/V(53.83b) * Rd(0.23%) * (1-Tc(0.28)))
Discount Rate = 13.67% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 28.62%
Fair Price DCF = unknown (Cash Flow -37.56b)
EPS Correlation: 24.05 | EPS CAGR: 13.02% | SUE: -2.51 | # QB: 0
Revenue Correlation: -49.47 | Revenue CAGR: -1.17% | SUE: 2.69 | # QB: 1
EPS next Quarter (2026-03-31): EPS=1.88 | Chg30d=+0.493 | Revisions Net=+0 | Analysts=3
EPS next Year (2026-12-31): EPS=38.08 | Chg30d=+5.355 | Revisions Net=+0 | Growth EPS=-1.4% | Growth Revenue=+2.8%
Additional Sources for MSTR Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle